More insurers will sell Obamacare plans on HealthCare.gov for 2015 enrollment than did this year, heartening advocates of the health-care reform law.» Read More
Using a technology that echoes science fiction, a company is offering people a place to store their stem cells in a bet that they may one day be used to grow replacement organs.
Both Pfizer and Merck are expected to report double-digit declines in top- and bottom-line growth when they announce earnings Tuesday.
U.S. generic drugmaker Perrigo agreed to buy fellow drug company Elan for $8.6 billion on Monday in a deal that will hand it royalty rights from a blockbuster treatment and tax savings from being domiciled in Ireland.
In a recent report, researchers found that blood pressure medication also functions to provide measurable relief for patients experiencing worsening Alzheimer's symptoms.
Had you bought this stock last week, you’d be pretty happy right now. How should you play it now?
Patients whose doctors sell their practices to hospitals could see prices rise, at least in the short term, experts say.
Biotech IPOs, after doing nothing for years, are suddenly hot. One came roaring out of the starting gate today, and several are pricing tonight.
More middle-age workers fear the financial consequences of a critical illness than fear dying from that illness, but few are preparing for that possibility, a survey finds.
"As a physician, I understand in a real way the damage Obamacare will to do medicine in South Dakota and the entire country," one of the doctors said in announcing her candidacy.
A growing epidemic of overdoses of prescription painkillers is leading to record numbers of deaths, especially among women, the Centers for Disease Control and Prevention says.
The chief executive of GlaxoSmithKline said the allegations of bribery and corruption in China were "deeply disappointing," as the company reported second-quarter results.
A Food and Drug Administration review concludes that menthol cigarettes pose a greater public health risk than regular cigarettes.
White House officials met with a group of Hollywood stars on Monday to talk about how to use pop culture to persuade young Americans to sign up for new medical coverage this fall.
In the rush to get the word out about Obamacare and set up state exchanges where insurance may be purchased, there inevitably are opportunities for fraud and abuse, analysts say.
Glaxo's problems may go beyond the sales practices that are currently at the center of a bribery and corruption scandal in China. They may extend to its Shanghai research and development center.
A poll of doctors finds huge skepticism that Obamacare insurance exchanges will open by fall deadline, and mostly don't know how new health law will affect practices.
GlaxoSmithKline CEO Andrew Witty will detail this week what action the drugmaker is taking in response to allegations of bribery against it in China, sources said.
A study of hospitals found a big disparity between official charges for hip- and knee-replacement surgeries, and that high-volume facilities are often the best choice.
Intuitive Surgical shares fell more than 11 percent after the company slashed its 2013 sales forecast due to disappointing demand for its da Vinci surgical robots and procedures.
President Barack Obama highlighted cost savings delivered by his health-care reform law, arguing that extra dollars in middle-class pockets trumps Republican opponents.
Get the best of CNBC in your inbox